Brief Buprenorphine Detoxification for the Treatment of Prescription Opioid Dependence: A Pilot Study

作者: Stacey C. Sigmon , Kelly E. Dunn , Gary J. Badger , Sarah H. Heil , Stephen T. Higgins

DOI: 10.1016/J.ADDBEH.2008.11.017

关键词:

摘要: We examined the feasibility of brief outpatient detoxification as a treatment for prescription opioid (PO) abusers. Fifteen PO-dependent adults were enrolled to receive buprenorphine stabilization, 2-week taper, and subsequent naltrexone those who completed taper. Subjects also received behavioral therapy, urinalysis monitoring, double-blind drug administration. provided 83.8%, 91.7% 31.2% opioid-negative samples during taper phases, respectively. Inspection individual subject data revealed systematic differences in whether subjects successfully without resumption illicit use. Post-hoc analyses used examine characteristics (Responders, n=5) vs. failed do so (Nonresponders, n=9). These pilot suggest subset PO abusers may respond detoxification, though future efforts should aim improve outcomes, investigate response identify that predict whom longer-term agonist is warranted.

参考文章(67)
THE MORPHINE ABSTINENCE SYNDROME, ITS NATURE AND TREATMENT* Annals of Internal Medicine. ,vol. 15, pp. 829- 839 ,(1941) , 10.7326/0003-4819-15-5-829
Karl Verebey, Jan Volavka, Salvatore J. Mule, R. B. Resnick, Naltrexone: Disposition, metabolism, and effects after acute and chronic dosing Clinical Pharmacology & Therapeutics. ,vol. 20, pp. 315- 328 ,(1976) , 10.1002/CPT1976203315
Hannah K. Knudsen, Lori J. Ducharme, Paul M. Roman, Controlled-Release Oxycodone Admissions in Public and Private Substance Abuse Treatment: Associations with Organizational Characteristics Journal of Addictive Diseases. ,vol. 26, pp. 41- 50 ,(2007) , 10.1300/J069V26N01_06
Maxine L. Stitzer, George E. Bigelow, Mark K. Greenwald, Mark K. Greenwald, Thomas Eissenberg, Rolley E. Johnson, Ira A. Liebson, Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans. Journal of Pharmacology and Experimental Therapeutics. ,vol. 276, pp. 449- 459 ,(1996)
Brent A. Moore, David A. Fiellin, Declan T. Barry, Lynn E. Sullivan, Marek C. Chawarski, Patrick G. O’Connor, Richard S. Schottenfeld, Primary Care Office-based Buprenorphine Treatment: Comparison of Heroin and Prescription Opioid Dependent Patients Journal of General Internal Medicine. ,vol. 22, pp. 527- 530 ,(2007) , 10.1007/S11606-007-0129-0
Warren K Bickel, Maxine L Stitzer, George E Bigelow, Ira A Liebson, Donald R Jasinski, Rolley E Johnson, A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts Clinical Pharmacology and Therapeutics. ,vol. 43, pp. 72- 78 ,(1988) , 10.1038/CLPT.1988.13
George M. Hunt, N.H. Azrin, A community-reinforcement approach to alcoholism Behaviour Research and Therapy. ,vol. 11, pp. 91- 104 ,(1973) , 10.1016/0005-7967(73)90072-7
Kyle M. Kampman, Helen M. Pettinati, Joseph R. Volpicelli, David M. Oslin, Craig Lipkin, Thorne Sparkman, Charles P. O'Brien, Cocaine dependence severity predicts outcome in outpatient detoxification from cocaine and alcohol. American Journal on Addictions. ,vol. 13, pp. 74- 82 ,(2004) , 10.1080/10550490490265389
K. Silverman, Mary Ann Chutuape, George E. Bigelow, Maxine L. Stitzer, Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude. Psychopharmacology. ,vol. 146, pp. 128- 138 ,(1999) , 10.1007/S002130051098
Rolley E. Johnson, A Controlled Trial of Buprenorphine Treatment for Opioid Dependence JAMA: The Journal of the American Medical Association. ,vol. 267, pp. 2750- 2755 ,(1992) , 10.1001/JAMA.1992.03480200058024